Personnel Announcement
NQ Score
0/100
N1 Content Completeness
6
AI Summary (NQ-processed)
Novo Nordisk Pharma Ltd. announced that Yukako Akiyama will be appointed as a Director effective June 1, 2026. Ms. Akiyama will continue to serve as General Manager of the Diabetes & Obesity Sales Division.
AI Analysis
Frequently Asked Questions
- Q: When does this personnel change take effect?
- A: It takes effect on June 1, 2026.
- Q: What is Yukako Akiyama's new position?
- A: She will become a Director and continue as General Manager of the Diabetes & Obesity Sales Division.
- Q: Which company made this announcement?
- A: Novo Nordisk Pharma Ltd.